Similar Efficacy of Bimekizumab in Two Clinical Endotypes of Axial Spondyloarthritis: 2- Year Results From Two Phase 3 Studies and Their Open- Label Extension (Update)

Bimzelx (bimekizumab-bkzx) - UCB

https://static1.squarespace.com/static/6642bbced8b22f3bcd7949a5/t/6a05b7ce0e0e4a17617431e0/1778759630269/APL_v29_iS2_Rev4.pdf

Mathew Reynolds1; Félicie Costantino2,3; Ann- Sophie de Craemer4,5; Filip Van den Bosch4,5; Maxime Breban6; Vanessa Taieb7; Diana Voiniciuc8; Natasha de Peyrecave9; Dirk Elewaut5,10; Maria- Antonietta D'Agostino11

May 26, 2026